Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Decreased nitric oxide (NO) bioavailability and increased lipid oxidation are associated with progressive endothelial dysfunction. L-Citrulline, the effective precursor of L-arginine which is essential as a substrate for endothelial NO synthase (eNOS), is effective in enhancing NO-dependent signaling. However, little is known about the efficacy of L-citrulline supplementation on lipoprotein oxidation and endothelial dysfunction. METHODS: Twenty-two patients (aged 41 - 64 years old) diagnosed with vasospastic angina with flow-mediated dilation (FMD) of the brachial artery (< 5.5 %) received 800 mg/day of L-citrulline for 8 weeks. FMD (%), blood NOx, asymmetric dimethylarginine (ADMA), small dense LDL, oxidized lipids, amino acids concentrations were measured before and after supplementation. RESULTS: Compared with baseline values, FMD (%) was significantly improved at 4 and 8 weeks as well as at 4 weeks after the end of intake. L-Citrulline supplementation caused a significant lowering of plasma ADMA levels. Plasma L-arginine/ADMA ratio and NOx levels rose markedly throughout the study period. Moreover, significant reductions of serum oxidized LDL and lectin-like oxidized LDL receptor 1 (LOX-1) ligand containing ApoB (LAB), an indicator of the biological activity of oxidized lipoprotein binding to LOX-1, were observed after L-citrulline intake. CONCLUSIONS: L-Citrulline supplementation improves endothelial dysfunction, probably due to potentiating NO-dependent reactions and decreasing the state of lipoprotein oxidation in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Almost all about citrulline in mammals
Curis, E., Nicolis, I., Moinard, C., Osowska, S., Zerrouk, N., Bénazeth, S., & Cynober, L. (2005) · Amino Acids · doi:10.1007/s00726-005-0235-4 · Cited by 571
Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02990.x · Cited by 494 · cited 2×
“A recent study reported that oral intake of L-citrulline dose-dependently increased plasma Larginine levels in healthy human volunteers more effectively than equivalent doses of L-arginine [12].”
BackgroundSchulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., et al. (2006) · JAMA · doi:10.1001/jama.295.1.58 · Cited by 357 · cited 1×
“However, the recent literature has reported no effects of chronic administration of L-arginine [25, 26], since orally administered L-arginine passes through the gastrointestinal tract and is trapped in the hepatic tissue, where it is extensively catabolized by arginase that also can be induced by dietary L-arginine [1…”
BackgroundDietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats
Fu, W. J., Haynes, T. E., Kohli, R., Hu, J., Shi, W., Spencer, T. E., Carroll, R. J., Meininger, C. J., & Wu, G. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.4.714 · Cited by 353
Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Short-term effects of l-citrulline supplementation on arterial stiffness in middle-aged men
Ochiai, M., Hayashi, T., Morita, M., Ina, K., Maeda, M., Watanabe, F., & Morishita, K. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.004 · Cited by 127 · cited 3×
“Our results indicate a significant reduction in plasma ADMA levels, and a significant improvement in Larginine/ADMA ratio, a marker of endothelial dysfunction [15, 30], after L-citrulline supplementation.”
BackgroundResultSelf-citationFigueroa, A., Sanchez-Gonzalez, M. A., Wong, A., & Arjmandi, B. H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.20 · Cited by 96
The Effect of L-citrulline Ingestion on ECG QT Interval and Autonomic Nervous System Activity
Kameda, N., Okigawa, T., Kimura, T., Fujibayashi, M., Asada, T., Kinoshita, R., Baba, S., Morita, M., Morishita, K., & Moritani, T. (2011) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.2114/jpa2.30.41 · Cited by 14 · cited 1×
“Moreover, we and others have revealed in clinical trials that L-citrulline supplementation functionally improves arterial stiffness [15], causes a reduction in the heart-rate corrected QT interval as a marker of sudden cardiac death [16], and decreases ankle blood pressure and carotid wave reflection [17].”
BackgroundSelf-citation
Cited by
Figueroa, A., Wong, A., Jaime, S. J., & Gonzales, J. U. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000340 · Cited by 147
Morita, M., Hayashi, T., Ochiai, M., Maeda, M., Yamaguchi, T., Ina, K., & Kuzuya, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.029 · Cited by 140
Self-citation
Metadata
- Authors
- Morita, M., Sakurada, M., Watanabe, F., Yamasaki, T., Doi, H., Ezaki, H., Morishita, K., & Miyake, T.
- Venue
- Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-12-31
- Volume
- 13
- Issue
- 3
- Pages
- 214-220
- ISSN
- 1871-5222 (ISSN-L)
- OpenAlex
- W2326262590
- Cited by
- 49
- References
- 9
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina. https://app.cochat.ai/papers/10.2174/18715222113139990008
- The paper
- Morita, M., Sakurada, M., Watanabe, F., Yamasaki, T., Doi, H., Ezaki, H., Morishita, K., & Miyake, T. (2013). Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina. Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry. https://doi.org/10.2174/18715222113139990008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.